CC-chemokine binding tick proteins

Details CC-chemokine binding tick proteins CC-chemokine binding tick proteins

2007-02-16

2009-11-03

Saoud, Christine J (Department: 1647)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S071100, C435S252300, C435S320100, C435S069500, C514S002600, C514S012200, C530S350000, C536S023400, C536S023500

Reexamination Certificate

active

07611867

ABSTRACT:
A novel CC-chemokine binding protein is isolated from the saliva ofRhipicephalus sanguineus. Compounds prepared in accordance with the present invention can be used as anti-inflammatory and immunomodulatory compounds and in the treatment or prevention of CC-chemokine-related diseases.

REFERENCES:
patent: 2003/0050244 (2003-03-01), Fuchsberger et al.
patent: 2007/0224125 (2007-09-01), Power et al.
patent: WO 2005/063812 (2005-07-01), None
Aljamali, M. N. et al. “RNA interference in ticks: a study using histamine binding protein dsRNA in the female tickAmblyomma americanum”, Insect Molecular Biology, 2003, pp. 299-305, vol. 12, No. 3.
Baggiolini, M. “Chemokines in Pathology and Medicine”,Journal of Internal Medicine, 2001, pp. 91-104, vol. 250.
Baggiolini, M. et al. “Human Chemokines: An Update”,Annu. Rev. Immunol., 1997, pp. 675-705, vol. 15.
Brown, A. R. et al. “The Total Chemical Synthesis of Monocyte Chemotactic Protein-1 (MCP-1)”,Journal of Peptide Science, 1996, pp. 40-46, vol. 2.
Chuang, V. et al. “Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin”,Pharmaceutical Research, May 2002, pp. 569-577, vol. 19, No. 5.
Clackson, T. et al. “Making antibody fragments using phage display libraries”,Nature, Aug. 15, 1991, pp. 624-628, vol. 352.
Dougherty, D. A. et al. “Unnatural amino acids as probes of protein structure and function”,Current Opinion in Chemical Biology, 2000, pp. 645-652, vol. 4.
Ferreira, B. R. et al. “Saliva ofRhipicephalus sanguineustick impairs T cell proliferation and IFN-γ-induced macrophage microbicidal activity”,Veterinary Immunology and Immunopathology, 1998, pp. 279-293, vol. 64.
Gendel, S. M. “Sequence Analysis for Assessing Potential Allergenicity”,Ann N.Y. Acad. Sci., 2002, pp. 87-98, vol. 964.
Gillespie, R. D. et al. “Identification of an IL-2 Binding Protein in the Saliva of the Lyme Disease Vector Tick,Ixodes scapularis”, The Journal of Immunology, 2001, pp. 4319-4327, vol. 166.
Goding, J.W. “Production of Monoclonal Antibodies”, Chapter 3 inMonoclonal Antibodies: Principles and Practice, 1986, pp. 59-103, Second Edition, Harcourt Brace Jovanovich, Publishers.
Hajnicka, V. et al. “Manipulation of host cytokine network by ticks: a potential gateway for pathogen transmission”,Parasitology, 2005, pp. 333-342, vol. 130.
Harris, J. M. et al. “Effect of Pegylation on Pharmaceuticals”,Nature Review Drug Discovery, Mar. 2003, pp. 214-221, vol. 2.
Hill, C.A. et al. “A method for extraction and analysis of high quality genomic DNA from ixodid ticks”,Medical and Veterinary Entomology, 2003, pp. 224-227, vol. 17.
Hoogenboom, H. R. et al. “By-passing Immunisation Human Antibodies from Synthetic Repertoires of Germline VHGene Segments Rearranged in Vitro”,J. Mol. Biol., 1992, pp. 381-388, vol. 227.
Hruby, V. J. et al. “Conformational and Topographical Considerations in Designing Agonist Peptidomimetics from Peptide Leads”,Current Medicinal Chemistry, 2000, pp. 945-970, vol. 7.
Jensen, K. K. et al. “Disruption of CCL21-Induced Chemotaxis In Vitro and In Vivo by M3, a Chemokine-Binding Protein Encoded by Murine Gammaherpesvirus 68”,Journal of Virology, Jan. 2003, pp. 624-630, vol. 77, No. 1.
Jones, P. T. et al. “Replacing the complementarity-determining regions in a human antibody with those from a mouse”,Nature, May 29, 1986, pp. 522-525, vol. 321.
Kocakova, P. et al. “Effect of fast protein liquid chromatography fractionated salivary gland extracts from different ixodid tick species on interleukin-8 binding to its cell receptors”,Folia parasitologica, 2003, pp. 79-84, vol. 50.
Luo, Y. et al. “Novel biomaterials for drug delivery”,Expert Opin. Ther. Patents, 2001, pp. 1395-1410, vol. 11, No. 9.
Madden, R. D. et al. “A proteomics approach to characterizing tick salivary secretions”,Experimental and Applied Acarology, 2002, pp. 77-87, vol. 28.
Marshall, S. A. et al. “Rational design and engineering of therapeutic proteins”,Drug Discovery Today, Mar. 5, 2003, pp. 212-221, vol. 8, No. 5.
Mulenga, A. et al. “Issues in tick vaccine development: identification and characterization of potential candidate vaccine antigens”,Microbes and Infection, 2000, pp. 1353-1361, vol. 2.
Murphy, L. R. et al. “Simplified amino acid alphabets for protein fold recognition and implications for folding”,Protein Engineering, 2000, pp. 149-152, vol. 13, No. 3.
Murrell, A. et al. “A Total-Evidence Phylogeny of Ticks Provides Insight into the Evolution of Life Cycles and Biogeography”,Molecular Phylogenetics and Evolution, Nov. 2001, pp. 244-258, vol. 21, No. 2.
Nilsson, J. et al. “Affinity Fusion Strategies for Detection, Purification, and Immobilization of Recombinant Proteins”,Protein Expression and Purification, 1997, pp. 1-16, vol. 11.
Pearson, W. R. “Flexible Sequence Similarity Searching with the FASTA3 Program Package”,Methods in Molecular Biology, 2000, pp. 185-219, vol. 132.
Pillai, O. et al. “Polymers in Drug Delivery”,Current Opinion in Chemical Biology, 2001, pp. 447-451, vol. 5.
Rapoport, T.A. et al. “Protein transport across the eukaryotic endoplasmic reticulum and bacterial inner membranes”,Annu. Rev. Biochem., 1996, pp. 271-303, vol. 65.
Rogov, S. I. et al. “A numerical measure of amino acid residues similarity based on the analysis of their surroundings in natural protein sequences”,Protein Engineering, 2001, pp. 459-463, vol. 14, No. 7.
Scatchard, G. “The Attractions of Proteins for Small Molecules and Ions”,Ann NY Acad. Sci., 1949, pp. 660-672, vol. 51.
Schellekens, H. “Bioequivalence and the Immunogenicity of Biopharmaceuticals”,Nature Reviews Drug Discovery, Jun. 2002, pp. 457-462, vol. 1.
Ullmann, A. J. et al. “A preliminary linkage map of the tick,Ixodes scapularis”, Experimental and Applied Acarology, 2002, pp. 107-126, vol. 28.
Vaitukaitis, J. et al. “A Method for Producing Specific Antisera with Small Doses of Immunogen”,J Clin Endocr, 1971, pp. 988-991, vol. 33.
Valenzuela, J. G. “Editorial: Exploring the Messages of the Salivary Glands ofIxodes ricinus”, Am. J. Trop. Med. Hyg., 2002, pp. 223-224, vol. 66, No. 3.
Van Valkenburgh, H. A. et al. “Coexpression of Proteins with Methionine Aminopeptidase and/or N-Myristoyltransferase inEscherichia colito Increase Acylation and Homogeneity of Protein Preparations”,Methods in Enzymology, 2002, pp. 186-183, vol. 344.
Vasserot, A. P. et al. “Optimization of protein therapeutics by directed evolution”,Drug Discovery Today, Feb. 2003, pp. 118-126, vol. 8, No. 3.
Villain, M. et al. “Covalent capture: a new tool for the purification of synthetic and recombinant polypeptides”,Chemistry&Biology, 2001, pp. 673-679, vol. 8.
Wang, H. “Molecular individuality: polymorphism of salivary gland proteins in three species of ixodid tick”,Experimental and Applied Acarology, 1999, pp. 969-975, vol. 23.
Ward, E. S. et al. “Binding activities of a repertoire of single immunoglobulin variable domains secreted fromEscherichia coli”, Nature, Oct. 12, 1989, pp. 544-546, vol. 341.
Kohler, G. et al. “Continuous cultures of fused cells secreting antibody of predefined specificity”,Nature, Aug. 7, 1975, pp. 495-497, vol. 256.

Affiliated with

Also associated with

Rating

CC-chemokine binding tick proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CC-chemokine binding tick proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CC-chemokine binding tick proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4098213